{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T20:05:31Z","timestamp":1773605131640,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Baxter (Asia) Pte Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13643-019-0959-y","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:02:42Z","timestamp":1548831762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"8","author":[{"given":"Monika","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"B\u00fchn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Breuing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"Firanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Nariai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Sloand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e4the","family":"Goossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"3","key":"959_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1681\/ASN.2011060607","volume":"23","author":"AK Jain","year":"2012","unstructured":"Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol: JASN. 2012;23(3):533\u201344.","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"2","key":"959_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrneph.2009.210","volume":"6","author":"N Lameire","year":"2010","unstructured":"Lameire N, Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol. 2010;6(2):75\u201382.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"959_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000363417","volume":"39","author":"SA Silver","year":"2014","unstructured":"Silver SA, Harel Z, Perl J. Practical considerations when prescribing icodextrin: a narrative review. Am J Nephrol. 2014;39(6):515\u201327.","journal-title":"Am J Nephrol"},{"issue":"6","key":"959_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","volume":"14","author":"K Honda","year":"1999","unstructured":"Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial, Transplant. 1999;14(6):1541\u20139.","journal-title":"Nephrol Dial, Transplant"},{"issue":"Suppl 5","key":"959_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ndt\/11.supp5.2","volume":"11","author":"A Mahiout","year":"1996","unstructured":"Mahiout A, Ehlerding G, Brunkhorst R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant. 1996;11(Suppl 5):2\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 5","key":"959_CR6","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1177\/089686080002005S03","volume":"20","author":"H Ha","year":"2000","unstructured":"Ha H, Yu MR, Choi HN, Cha MK, Kang HS, Kim MH, Lee HB. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int. 2000;20(Suppl 5):S10\u20138.","journal-title":"Perit Dial Int"},{"issue":"2","key":"959_CR7","first-page":"67","volume":"2","author":"H Hain","year":"1987","unstructured":"Hain H, Kessel M. Aspects of new solutions for peritoneal dialysis. Nephrol Dial Transplant. 1987;2(2):67\u201372.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"959_CR8","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/ndt\/gft050","volume":"28","author":"Y Cho","year":"2013","unstructured":"Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2013;28(7):1899\u2013907.","journal-title":"Nephrol Dial Transplant"},{"key":"959_CR9","doi-asserted-by":"crossref","unstructured":"Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2014;(3):Cd007554.","DOI":"10.1002\/14651858.CD007554.pub2"},{"issue":"2","key":"959_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3747\/pdi.2009.00264","volume":"31","author":"H Qi","year":"2011","unstructured":"Qi H, Xu C, Yan H, Ma J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int. 2011;31(2):179\u201388.","journal-title":"Perit Dial Int"},{"key":"959_CR11","doi-asserted-by":"crossref","unstructured":"Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Biocompatible dialysis fluids for peritoneal dialysis. The Cochrane database of systematic reviews. 2018;(10):Cd007554.","DOI":"10.1002\/14651858.CD007554.pub3"},{"issue":"10","key":"959_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3109\/0886022X.2011.615965","volume":"33","author":"Q He","year":"2011","unstructured":"He Q, Zhang W, Chen J. A meta-analysis of icodextrin versus glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients. Ren Fail. 2011;33(10):943\u20138.","journal-title":"Ren Fail"},{"key":"959_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"959_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jrsm.1260","volume":"8","author":"R Suurmond","year":"2017","unstructured":"Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of Meta-Essentials: a free and simple tool for meta-analysis. Res Synth Methods. 2017;8(4):537\u201353.","journal-title":"Res Synth Methods"},{"issue":"4","key":"959_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"959_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"issue":"7","key":"959_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-0959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-019-0959-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-0959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:06:30Z","timestamp":1606287990000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-019-0959-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1186\/s13643-019-0959-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"18 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB, SB, JB, SH, KG, and DP declare that they have no competing interests. MRM, JAS, CAF, HN and QY are all full-time employees of Baxter Healthcare International and its subsidiaries.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}